Martin Dreyling • Michael E. Williams
Editors

2014

The non-Hodgkin lymphomas represent one of the most prevalent cancer types worldwide, comprised of a complex and fascinating array of malignancies that are in turn diverse in cell of origin, pathogenesis and clinical presentation. Rapid progress during the past decade in hematopathology and molecular diagnostics have defined more than 50 distinct entities in the current World Health Organization classification, leading to continuous refinement in treatment approach and, for many lymphomas, improving outcomes and survival.